Literature DB >> 35813487

Machine Learning-Based Prediction of Impulse Control Disorders in Parkinson's Disease From Clinical and Genetic Data.

Johann Faouzi1, Samir Bekadar2, Fanny Artaud3, Alexis Elbaz3, Graziella Mangone2, Olivier Colliot1, Jean-Christophe Corvol2.   

Abstract

Goal: Impulse control disorders (ICDs) are frequent non-motor symptoms occurring during the course of Parkinson's disease (PD). The objective of this study was to estimate the predictability of the future occurrence of these disorders using longitudinal data, the first study using cross-validation and replication in an independent cohort.
Methods: We used data from two longitudinal PD cohorts (training set: PPMI, Parkinson's Progression Markers Initiative; test set: DIGPD, Drug Interaction With Genes in Parkinson's Disease). We included 380 PD subjects from PPMI and 388 PD subjects from DIGPD, with at least two visits and with clinical and genetic data available, in our analyses. We trained three logistic regressions and a recurrent neural network to predict ICDs at the next visit using clinical risk factors and genetic variants previously associated with ICDs. We quantified performance using the area under the receiver operating characteristic curve (ROC AUC) and average precision. We compared these models to a trivial model predicting ICDs at the next visit with the status at the most recent visit.
Results: The recurrent neural network (PPMI: 0.85 [0.80 - 0.90], DIGPD: 0.802 [0.78 - 0.83]) was the only model to be significantly better than the trivial model (PPMI: ROC AUC = 0.75 [0.69 - 0.81]; DIGPD: 0.78 [0.75 - 0.80]) on both cohorts. We showed that ICDs in PD can be predicted with better accuracy with a recurrent neural network model than a trivial model. The improvement in terms of ROC AUC was higher on PPMI than on DIGPD data, but not clinically relevant in both cohorts. Conclusions: Our results indicate that machine learning methods are potentially useful for predicting ICDs, but further works are required to reach clinical relevance.

Entities:  

Keywords:  Impulse control disorders; Parkinson’s disease; machine learning; precision medicine

Year:  2022        PMID: 35813487      PMCID: PMC9252337          DOI: 10.1109/OJEMB.2022.3178295

Source DB:  PubMed          Journal:  IEEE Open J Eng Med Biol        ISSN: 2644-1276


  46 in total

Review 1.  Caregiver Burden and the Nonmotor Symptoms of Parkinson's Disease.

Authors:  Jon P Hiseman; Robin Fackrell
Journal:  Int Rev Neurobiol       Date:  2017-07-21       Impact factor: 3.230

Review 2.  Impulse Control and Related Disorders in Parkinson's Disease.

Authors:  Daniel Weintraub; Daniel O Claassen
Journal:  Int Rev Neurobiol       Date:  2017-06-01       Impact factor: 3.230

3.  Apathy and impulse control disorders in Parkinson's disease: a direct comparison.

Authors:  Iracema Leroi; Michelle Andrews; Kathryn McDonald; Vijay Harbishettar; Rebecca Elliott; E Jane Byrne; Alistair Burns
Journal:  Parkinsonism Relat Disord       Date:  2011-10-28       Impact factor: 4.891

4.  Impulse control disorders in Parkinson disease: a multicenter case--control study.

Authors:  Valerie Voon; Mandy Sohr; Anthony E Lang; Marc N Potenza; Andrew D Siderowf; Jacqueline Whetteckey; Daniel Weintraub; Glen R Wunderlich; Mark Stacy
Journal:  Ann Neurol       Date:  2011-03-17       Impact factor: 10.422

5.  Next-generation genotype imputation service and methods.

Authors:  Sayantan Das; Lukas Forer; Sebastian Schönherr; Carlo Sidore; Adam E Locke; Alan Kwong; Scott I Vrieze; Emily Y Chew; Shawn Levy; Matt McGue; David Schlessinger; Dwight Stambolian; Po-Ru Loh; William G Iacono; Anand Swaroop; Laura J Scott; Francesco Cucca; Florian Kronenberg; Michael Boehnke; Gonçalo R Abecasis; Christian Fuchsberger
Journal:  Nat Genet       Date:  2016-08-29       Impact factor: 38.330

6.  Impulsive and compulsive behaviors in Parkinson's disease: Impact on quality of and satisfaction with life, and caregiver burden.

Authors:  Aleksander H Erga; Guido Alves; Ole Bjørn Tysnes; Kenn Freddy Pedersen
Journal:  Parkinsonism Relat Disord       Date:  2020-07-09       Impact factor: 4.891

7.  NeuroX, a fast and efficient genotyping platform for investigation of neurodegenerative diseases.

Authors:  Mike A Nalls; Jose Bras; Dena G Hernandez; Margaux F Keller; Elisa Majounie; Alan E Renton; Mohamad Saad; Iris Jansen; Rita Guerreiro; Steven Lubbe; Vincent Plagnol; J Raphael Gibbs; Claudia Schulte; Nathan Pankratz; Margaret Sutherland; Lars Bertram; Christina M Lill; Anita L DeStefano; Tatiana Faroud; Nicholas Eriksson; Joyce Y Tung; Connor Edsall; Noah Nichols; Janet Brooks; Sampath Arepalli; Hannah Pliner; Chris Letson; Peter Heutink; Maria Martinez; Thomas Gasser; Bryan J Traynor; Nick Wood; John Hardy; Andrew B Singleton
Journal:  Neurobiol Aging       Date:  2014-08-04       Impact factor: 4.673

8.  Dopaminergic and Opioid Pathways Associated with Impulse Control Disorders in Parkinson's Disease.

Authors:  Aleksander H Erga; Ingvild Dalen; Anastasia Ushakova; Janete Chung; Charalampos Tzoulis; Ole Bjørn Tysnes; Guido Alves; Kenn Freddy Pedersen; Jodi Maple-Grødem
Journal:  Front Neurol       Date:  2018-02-28       Impact factor: 4.003

Review 9.  SciPy 1.0: fundamental algorithms for scientific computing in Python.

Authors:  Pauli Virtanen; Ralf Gommers; Travis E Oliphant; Matt Haberland; Tyler Reddy; David Cournapeau; Evgeni Burovski; Pearu Peterson; Warren Weckesser; Jonathan Bright; Stéfan J van der Walt; Matthew Brett; Joshua Wilson; K Jarrod Millman; Nikolay Mayorov; Andrew R J Nelson; Eric Jones; Robert Kern; Eric Larson; C J Carey; İlhan Polat; Yu Feng; Eric W Moore; Jake VanderPlas; Denis Laxalde; Josef Perktold; Robert Cimrman; Ian Henriksen; E A Quintero; Charles R Harris; Anne M Archibald; Antônio H Ribeiro; Fabian Pedregosa; Paul van Mulbregt
Journal:  Nat Methods       Date:  2020-02-03       Impact factor: 28.547

10.  Evolution of impulsive-compulsive behaviors and cognition in Parkinson's disease.

Authors:  Aleksander H Erga; Guido Alves; Ole Bjørn Tysnes; Kenn Freddy Pedersen
Journal:  J Neurol       Date:  2019-10-18       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.